In 1988, Dr. Alberto Bossi obtained his degree in Medicine and Surgery at the University of Pavia, Italy. Between 1989 and 1990, he worked as clinical fellow at the Department of Radiotherapy of the Circolo Hospital in Varese, Italy. In 1991, he worked as clinical fellow at the Radiotherapy department of the Academic Medical Centre in Amsterdam, The Netherlands. Dr. Bossi specialized in 1992 in Radiotherapy and Oncology at the University of Pavia, Italy Between 1991 and 2000, Dr. Bossi was an assistant in Radiotherapy at the S. Anna Hospital in Como (Italy). From 2000-2001, he worked at the Radiotherapy unit at the S. Pio X° Hospital in Milan (Italy). He was then appointed Adjunct Clinical Head at the Department of Radiotherapy of the University of Leuven, Belgium where he worked from 2001 to 2006. He is currently Clinical Head of the urology section at the Department of Radiotherapy of the Institut Gustave Roussy in Villejuif, France. Dr. Bossi is member of several scientific organizations and societies, including the European Society for Therapeutic Radiation Oncology (ESTRO), the American Society of Radiation Oncology (ASTRO), the Italian Association of Radiation Oncology (AIRO) and the Radiation Oncology group of the European Organisation for Research and Treatment of Cancer (EORTC). He is a teacher at both the European School of Oncology and the European School of Radiotherapy. In 2006, Dr. Bossi was elected as coordinator of the Genito-Urinary Working Group of the EORTC. Dr. Bossi is reviewer for several journals, including the International Journal for Radiation Oncology, Biology and Physics, the Annals of Oncology and Tumori.

Dr. Chlosta is head of the Department of Urology at the Institute of Oncology, Kielce, Poland. He is surgeon since 1995 and works as consultant urologist since 1998. Dr. Chlosta is member of several scientific associations, including the Polish Urological Association, the European Association of Urology, the American Urological Association and the Societe Internationale d’Urologie. He is section editor for the international literature review of the Polish Journal of Urology. He is also member of the Residency Review Committee of the European Board of Urology and secretary of the Education Committee of the Polish Urological Association. His main professional and scientific interests are urological oncology and laparoscopy. Dr. Chlosta is author of several original and reviewed articles and book chapters. He is married and has a beloved son of 14 years old.

Dr. Francisco Gómez Veiga studied Medicine at the University of Santiago de Compostela (Spain), where he obtained his PhD in Medicine. During 1988-1993 he completed his internship training in urology at the University A Coruna Hospital, where he received his degree as MD. From this period on, his main activities have been concentrating on kidney transplant and Uro-Oncology. At the moment he is acting as coordinator of the oncology section. Dr. Gómez Veiga received training in different European and US hospitals concentrating on different techniques and aspects of kidney transplant and oncology, particularly prostate cancer. He has been the coordinator and member of the steering committee of more than 30 clinical trials, mainly focusing on the various aspects of oncology. Dr. Gómez Veiga is co-author of more than 85 published national and international articles. Also, he has collaborated in the publication of 16 books related to kidney and uro-oncology. He is peer reviewer of the urological journal “Actas and Archives of Spanish Urology” and member of the scientific committee of the Spanish guidelines on prostate cancer. Dr. Gómez Veiga has received awards from the Spanish Urologial Association, European Urological Association and Société Internationale d´Urologie as recognitions for his outstanding publications and presentations.

Axel Heidenreich is Professor of Urology and Chairman and Director of the department of Urology, University Hospital, RWTH Aachen, Germany since December 2008. He received his medical degree from the University of the Health Sciences, San Antonio, Texas and the Johannes Gutenberg Universität Mainz. Prof. Heidenreich’s main interest concentrates on operative and conservative uro-oncology, andrology and microsurgery and plastic/reconstructive surgery. Prof. Heidenreich has published more than 200 articles in peer reviewed journals and he has published several books on prostate cancer and urologic surgery. With regard to his basic research work in molecular pathogenesis and prognosis of urological malignancies, he was awarded with several prices including the prestigious Maximilian-Nitze-Award of the German Association of Urology. Prof. Heidenreich is board member of the Association of Urological Oncology of the German Cancer Society, board member of the German Testicular Cancer Study Group, board member of the “German Prostate Cancer Guideline Group” and board member of the German TNM classification group of urogenital cancer. He is chairman of the “Prostate Cancer Guidelines“ of the European Association of Urology and board member of the European Society for Oncological Urology of the EAU. He is also member of the editorial board of European Urology.

Prof. Jaques Irani studied medicine and received his PhD in clinical epidemiology and statistics. Currenly, he is Professor of Urology at the University Hospital Centre « La Milétrie », Poitiers, France were he qualified in Urological Oncology. His main research interests in this field are Uro-oncology. Prof. Irani is member of several national and international associations and societies including the Uro-Oncology committee of the French Association of Urology (AFU), the Scientific committee of the AFU, and the Board of the European Association of Urology Guidelines Committee. Prof. Irani is also member of several Editorial boards, including European Urology, Progrès en Urologie Formation continue and Annales d’urologie. He is also Member of the Executive Board of BJU International. Prof. Irani published over 140 publications in both national and international journals.

Prof. Eric Lechevallier studied medicine at the University of Marseille, where he specialised in Urological Surgery. Between 1991-1995, he worked as an Assistant-Hospital Chief. He followed several exchange programs in the USA including the European Association of Urology/American Urological Association Academic Exchange Program (1995, John Hopkins Hospital, Baltimore; Bowman Gray Hospital, Winston-Salem; Washington University, St. Louis; MD Anderson Cancer Center, Houston), Urology Prectorship Program (1995, Denver), Post-graduate course of Urology (1996, New York) and the Preceptorship Program (2004, Cleveland). In April 2000, Prof. Lechevallier became University Professor at the Salvator Hospital in Marseille. Currently, he works in that same hospital at the Department of Urology and Renal Transplantation. His main research interests are oncology (kidney, genital organs), renal transplantation, endourology of the upper urinary tract and urinary lithiasis. Since November 2002, Prof. Lechevallier is Fellow of the European Board of Urology. He is also member of several national and international Associations and Societies including the European Association of Urology, the Society of Endourology and the European Society of Transplantation. He is the former responsible for the Transplantation Committee of the Association Française d’Urologie (AFU) ". Prof. Lechevallier published over 200 publications in both national and international journals. Currently, he is Editor-in-Chief of Progrès en Urologie.

Dr. Andrea Mancuso works as oncologist at the department of medical oncology at the San Camillo/Forlanini Hospital in Rome, Italy. He obtained his MD from the ‘La Sapienza’ University in Rome in 1998. Afterwards, he was trained in medical oncology at the National Academy of Medicine at the S.Eugenio Hospital in Rome (1997-1998) and he did a fellowship in medical oncology at the department of experimental medicine and pathology of the ‘La Sapienza’ university in Rome (1998-2003). In addition, he successfully completed a course in ‘Physician-patient communication in cancer care’ from the Swiss Cancer League (2005). He followed several specific training courses about research and therapies in oncology. Before Dr. Mancuso was appointed oncologist at the medical oncology department of the San Camillo/Forlanini Hospital in Rome in 2005, he gained experience in oncology at several other places. He worked subsequently at the thoracic head and neck medical oncology department of the M.D. Anderson Cancer Center in Houston, USA (2002-2003), at the pneumo-oncology unit of the department of respiratory diseases at the San Camillo/Forlanini Hospital in Rome (2003-2004), at the ‘Madre Giuseppina Vannini’ Hospital in Rome (2004) and at the medical oncology department of the Oncology Institute of Southern Switzerland in Bellinzona, Switzerland (2004-2005). Dr. Mancuso’s research interest is focused on translational and clinical research. He is co-investigator in several randomized clinical trials evaluating new drugs for different types of cancer. He was awarded several grants for his research, including a scholarship from the European School of Oncology Foundation and a grant from the American-Italian Cancer Foundation. He is (co-)author of 24 research articles and 5 book chapters on oncology-related topics. In addition, he acts as reviewer for several journals including ‘Annals of Oncology’, ‘British Journal of Urology’, ‘Future Drugs’ and ‘Lung Cancer’. Furthermore, he is a frequently invited guest speaker and chairman at national and international oncology congresses. Dr. Mancuso is also member of several national and international oncology societies such as the ‘European School of Oncology’, the ‘American Society of Clinical Oncology’, the ‘European Society of Medical Oncology’, the ‘New York Academy of Sciences’, the ‘American Association for Cancer Research’, the ‘American Chemical Society’ and the ‘Thoracic Oncology Association’.

Dr. Nicolas Mottet is head of the department of Urology at Clinique Mutualiste in Saint-Etienne, France. Dr. Mottet is board certified in surgery, urology and medical oncology in France. He obtained his MD and his PhD from University Montpellier I. Dr. Mottet is coordinator of the Testis and Penis cancer subgroup for the Oncologic committee of the French Urological Association and secretary of the Urologic study group for the National Federation of anti-Cancer Centers. He has published over 80 peer reviewed papers, mainly on urologic oncology and prostatic disorders. He is on the scientific advisory board of several pharmaceutical and biotech companies in urology and oncology drug development and clinical trials and has coordinated or participated to more than 35 clinical studies. Dr. Mottet has received several peer reviewed grants and is currently coordinating studies on prostate and bladder cancer. He is member of several scientific and medical societies, including the American, the European and the French Urology Associations, and the European and the American Societies of Clinical Oncology. He is also a member of the New York Academy of Science.

Prof. Laurent Salomon is consultant at the Department of Urology at the Henri Mondor hospital in Créteil, France. He obtained a master’s degree in biological and medical sciences, focusing on general anatomy and organogenesis at the medical faculty of Saints-Pères in Paris, France (1990) and on radio-anatomy at the faculty Broussais-Hôtel Dieu in Paris (1992). He received a diploma in surgery sciences, option oncology, at the faculty Paris V in 1993 and he was accredited as general surgeon and urologist in 1995. Afterwards, he did research on laparoscopic radical prostatectomy at the faculty Paris XI, resulting in a PhD degree in surgical sciences in 2003. Prof. Salomon is active at the Department of Urology at the Henri Mondor hospital in Créteil since 1995. He also did a fellowship at the Department of Urology at the Presbyterian Hospital (College of Physicians and Surgeons, Colombia University) in New York, USA (2002). Currently, he is responsible for the multidisciplinary consultation unit in uro-oncology at the Henri Mondor hospital in Créteil. In 2006, he was appointed University Professor at the same hospital. He is teaching uro-nephrology and surgery semiology and he is lecturer at the school of nurses. Prof. Salomon is (co-)author of about 160 peer-reviewed research articles. Moreover, he contributed to more than 20 didactic and pedagogic books. In addition, he acts as a reviewer for several national and international journals including ‘Journal of Urology’, ‘European Urology’ and ‘Progrès en Urologie’. He is also reviewer of the abstracts for the annual meeting of the ‘European Urology Association’. Furthermore, Prof. Salomon is member of several national and international urology societies such as the ‘French College of Urology’, the ‘European Urology Association’ and the oncology committee and the transplantation committee of the ‘French Urology Association’.

Prof. Michel Soulié studied medicine at the University Paul Sabatier in Toulouse, where he obtained his PhD in medicine in 1987. He was awarded with a silver medal for his thesis on “radical prostatectomy” in 1988. Between 1988-1992, he worked at the urological surgery department (Prof. F. Pontonnier) at the University Hospital from Toulouse-Rangueil. Since May 1992, Prof. Soulié works at the department of Urology ,Andrology and Renal Transplantation (Prof. P. Plante) of the same hospital. He specialised in Urology in 1994 and in Oncology in 1999. In 2003, Michel Soulié became University Professor in Urology. His main topics and research interests in Oncology are epidemiology of cancers and prostate cancer. Prof. Soulié is member of several national and international associations and committees including the French Urological Association (AFU) and the European Association of Urology (EAU). He was Chairman of the Board of Urological Pathology at the French National Cancer Institute (INCa) from 2005 to 2008. He is chairman of the French Oncology Committee for Cancer of AFU (CCAFU) since 2008. Prof. Soulié has published over 120 publications in both national and international journals.

Dr. Arnoud Templeton works as a senior clinical and research fellow at the Department of Medical Oncology Kantonsspital St. Gallen and for the Swiss Group for Clinical Cancer Research (SAKK) as Medical Advisor. He graduated in medicine at the university of Basel and gained his MD in 2003. He completed his medical training in St. Gallen with the Swiss board certification in Internal Medicine. Dr. Templeton received his oncology specialist training at the Kantonsspital St. Gallen. He attended the Flims Workshop Methods in Clinical Cancer Research in 2008, passed the ESMO exam in 2009 and gained the Swiss Board Certification in Medical Oncology in 2010. His major clinical and research interest is prostate cancer. He has been co-investigator in several phase I – III trials and is trial Chair of multicentre trials conducted in Switzerland. Dr. Templeton is a member of a number of societies, including the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the Swiss Medical Association (FMH).

Jeroen van Moorselaar studied medicine at the University of Nijmegen in the Netherlands and obtained his medical degree in June 1987. He continued his career as research fellow in the urological research laboratory of the Urology department at the University Hospital in Nijmegen where he did his PhD in 1991 entitled ‘Cytokine Therapy in Experimental Urological Cancer’. He was certified as urologist in June 1997. From that time he has worked in the University Hospital in Nijmegen in the urological department and in April 1998 he moved to the University Hospital in Utrecht where he worked until August 2005. In September 2005 he became the head of the urological outpatient department in the Free University of Amsterdam where he still works, but since August 2008 in the position of Chairman of the department of Urology. He is member of various national and international organizations. He is an active researcher in the field of urological oncology and BPH. He has published in several medical journals and chapters of books. He is member of the Dutch working party on urological oncological guidelines and member of the scientific committee of the Dutch Urological Association. As member of the EORTC GU group he has participated in many academic and clinical trials. Since May 2007 he is board member of the European School of Urology. Furthermore he is chairman of the video committee of the European Association of Urology and editor-in-chief of the European Urology Video Journal.